Christoph Gasteyger

There are 1 included publications by Christoph Gasteyger :

TitleDateViewsBrief Description
Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome 2023 Background\r\nAtypical haemolytic uraemic syndrome (aHUS) is a rare, potentially life-threatening condition caused by dysregulation of the complement pathway. Eculizumab is currently the only approved treatment for this disorder.\r\n\r\nObjective\r\n...